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INTRODUCTION  
Microspheres can be defined as solid, approximately  
spherical part icles ranging in size from 1 to 1000 µm
1
. They 
are made from polymeric, waxy, or other protective materials 
such as starches, gums, proteins, fats and waxes and used as 
drug carrier matrices for drug delivery. A lbumin and gelatin  
are among the natural polymers which are used in 
preparation of microspheres. Preparation of uniformly sized  
AMS was first reported in the late 60’s and early 70’s2,3,4. 
AMS have received wide attention during the recent decades 
due to their specificity
5
, biodegradability
6 
and other desirable 
characteristics such as non-toxicity and biocompatibility
7
 as 
an ideal drug carrier. More than 100 therapeutic and 
diagnostic agents have been incorporated into albumin  
microspheres and drugs of various therapeutic categories 
such as nifedipine
8,9
 mitoxantrone
10
, dexamethasone
11
, 
salbutamol sulfate
12
 have been prepared and characterized as 
AMS delivery systems. Two methods have been developed 
for the preparation of albumin microspheres which include 
heat stabilization and chemical cross -linking by using 
glutaraldehyde
13
.  
Propranolol is a beta adrenergic blocking agent which is 
widely used in the treatment of angina pectoris, high blood 
pressure and migraine prophylaxis. The need for controlled  
systemic delivery of propranolol by some convenient 
delivery system is well established and a microsphere 
prepared from Human Serum Albumin (HSA) was one of 
those systems which were studied for its nasal delivery
14
.  
 
Due to variable absorption rates and high first pass 
metabolism of the oral route, several other researchers have 
also attempted to deliver propranolol via nasal route
15,16
. The 
aim of the present study was to prepare and characterize 
Bovine Serum Albumin (BSA) microspheres loaded with 
propranolol hydrochloride. BSA microspheres were prepared 
by an emulsificat ion technique and stabilized by heat 
denaturation. The prepared microspheres were then studied 
for their part icle size, size distribution, release 
characteristics, bioadhesion and drug diffusion profile across 
the rat intestine.   
MATERIALS AND METHODS  
Materials 
Bovine Serum Albumin and sorbitan monooleate (Span®80) 
were from Fluka (Switzerland), Propranolol Hydrochloride 
was obtained from IPCA Laboratory Ltd. Mumbai, 
Polyoxyethylene sorbitan monooleate (Tween®80), glacial 
acetic acid, potassium dihydrogen phosphate, dipotassium 
hydrogen phosphate, disodium hydrogen phosphate and 
sodium chloride were from Merck (Germany). Pure maize oil 
and petroleum ether was purchased from CDH Lab., New-
Delh i. A ll chemicals were of analytical grade.  
Preparation of BSA micros pheres  
BSA microspheres containing propranolol hydrochloride 
were prepared by emulsificat ion-heat stabilization technique 
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described previously
12
 with slight modifications. Briefly, a  
5% solution of BSA containing 0.1% Tween® 80 was made 
to which 4% propranolol hydrochloride was added and used 
as the aqueous phase. The oil phase composed of 30 ml 
maize oil and 10 ml petroleum ether with 1% Span® 80 as 
emulsifier were mixed together and allowed to stir for 10 min  
at 1000 rpm.  
The aqueous phase was added dropwise to the oil phase and 
stirred on a magnet stirrer at 1000 rpm for 30 min  to form the 
initial emulsion. This emulsion was then added to 40 ml of 
maize oil p reheated to 120°C and stirred at 1000 rpm for 15 
min to allow the format ion and solidification of 
microspheres. The microsphere suspension was centrifuged 
at 3500 rpm for 30 min and the settled micro- spheres were 
washed three times with ether to remove traces of oil on 
microsphere surfaces. The microspheres were vacuum dried  
in a desiccator overnight and stored at 4ºC in dark. Three 
batches of microspheres were prepared by the above 
mentioned method and marked as MC1, MC2 and MC3.  
Analytical Method
19
  
To determine the loading capacity, drug release and 
diffusion, the analysis of propranolol hydrochloride was 
carried out by UV-spectroscopy (Shimadzu uv/vis 160A, 
Japan). The absorption spectra of propranolol were obtained 
in distilled water, phosphate buffer saline (PBS, pH 6.8) and 
0.1 M acetic acid and its absorption maxima (λ max) were 
found at wavelengths of 215, 216 and 230 nm in the above 
three media respectively.  
Determination of the drug content
19
  
Ten mg of the dispersion of microspheres in distilled water 
was centrifuged at 5000 rpm for 15 min. In order to 
determine surface drug, the supernatant was assayed for 
propranolol hydrochloride content by a spectrophotometric 
method at 216 nm. The settled microspheres were completely  
hydrolyzed in 0.1 M acetic acid and assayed for 
determination of bulk drug content as mentioned above.  
Determination of mucoadhesion
20
 
BSA microspheres were tested for mucoadhesion using the 
method described by Ranga Rao and Buri
17
. Five cm length 
rat jejunum was cut longitudinally and placed on a 
polyethylene support (a tube with 2 cm diameter cut 
longitudinally at its center) and held in position with the aid  
of pins. A suspension containing 5 mg of BSA microspheres 
was poured dropwise at the mucosal site of the rat jejunum 
and placed in a desiccator maintained at 80% relative 
humid ity for 20 min to allow the microspheres to hydrate and 
to interact with the mucus glycoprotein and also to prevent 
drying of mucus.  
After 20 min, the polyethylene support was introduced into a 
plastic tube cut in a similar manner and held in inclined 
position. The mucosal lumen was thoroughly rinsed with 
PBS pH 6.8 at the rate of 5ml/min with the aid of a burette 
tube the tip of which was placed 2-3 cm over the 
microsphere bearing tissue so that the liquid was able to flow 
evenly over the mucosa. The washings were collected into a 
beaker and the microspheres in the perfusate were settled by 
centrifugation, dried at 50°C and weighed. The ratio of 
adhered to applied microspheres was computed as percent 
adhesion. 
Determination of size distribution of micros pheres
21
 
The microspheres were sized and photographed in normal 
saline containing 0.1% Tween 80 to prevent aggregation 
under a light microscope (Olympus C 011, Japan) equipped 
with an ocular micrometer and a light camera (Seagul DF-1, 
China). Two hundred microspheres were sized by the above 
mentioned method and the mean diameter as well as size 
distribution of microspheres were determined. 
Release studies
22 
In vitro release of propranolol hydrochloride from BSA 
microspheres was determined in a USP dissolution apparatus 
(Pharma Test PTWS, D-63512, Germany) using paddle 
method with six flasks in PBS pH 6.8 at 37±0.5ºC. The 
contents of the flasks were stirred at 100 rpm. Samples were 
taken at 15 min intervals for the first two hours and every 
one hour afterwards up to 12 hours and assayed 
spectrophotometrically at 216 nm wavelength as mentioned 
above.  
In vitro diffusion studies
22
 
Diffusion of propranolol hydrochloride from BSA 
microspheres across the rat duodenum was studied using a 
Franz diffusion cell. Rat duodenum was removed and the 
mucosal side was washed with PBS pH 6.8 in order to 
remove any debris and cut into equal segments with about 1 
cm
2
 surface area. Ten mg of BSA-propranolol hydrochloride 
microspheres was placed on the mucosal side of an intestinal 
segment and kept for 30 min to allow complete 
mucoadhesion. An intestinal segment bearing BSA 
propranolol hydrochloride microspheres was placed between 
the donor and receptor compartments of the diffusion cell 
which contained 5 and 26 ml PBS pH 6.8 respectively and 
maintained at 37ºC. Samples were withdrawn at 1 hour 
intervals for 12 hours and their drug content was determined 
by the spectrophotometer at 216 nm wavelength as 
mentioned before.   
RES ULTS AND DISCUSS ION 
In the present study BSA microspheres encapsulated with 
propranolol hydrochloride were prepared by an 
emulsification technique. Two hundred microspheres of each 
batch were sized by a light microscope equipped with an 
optical micrometer and the average percentage frequency 
was plotted against size ranges (Fig. 1).           
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Figure 1: Size range vs. average frequency of three batches of BSA-propranolol hydrochloride microspheres prepared by heat 
denaturation method. Two hundred microspheres of each batch were sized in a light microscope equipped with an optical 
micrometer and plotted as the mean percentage of total microspheres present in each size range. 
The mean size range of the three batches of microspheres 
was estimated between 1-25 µm with nearly 60% ly ing 
between 1-5 µm. It has earlier been reported that BSA-
salbutamol microspheres prepared with various albumin  
concentrations for pulmonary delivery showed almost the 
same size range for microspheres prepared with 5% 
albumin
12
. 
 
Figure 2: Optical micrograph of BSA-propranolol hydrochloride microspheres stabilized by heat denaturation method with an 
average size range of 1-25 µm, taken by a camera mounted light microscope (x1600). As it indicates microspheres have 
spherical shape. 
The microspheres were also photographed by an optical 
camera (Fig. 2) and as it shows microspheres are spherical 
with quite smooth surfaces. It has previously been suggested 
that heat stabilized albumin microspheres exhib it better size 
distribution and surface characteristics
13
. Drug loading was 
found to be between 7.5- 10.4% for three batches with an 
average value of about 9%. It was also found that about 25% 
of the total encapsulated drug was present on the surface of 
microspheres. In a study on mitoxantrone-albumin  
microspheres prepared by chemical cross -linking with 
glutaraldehyde, 8.2% drug loading was achieved
10
. 
Another group of researchers reported that various factors 
such as drug to albumin rat io, concentration of surfactant, 
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stirring rate of the emulsion and average size of microspheres 
could affect drug loading
8
. They found that drug loading 
could be increased by increasing drug to albumin ratio, 
decreasing surfactant concentration and increasing the 
stirring rate. In another study albumin microspheres loaded 
with terbutalin sulfate were prepared by a chemical cross 
linking method using glutaraldehyde and achieved 60% drug 
loading
18
. Since the size range reported by this group was 
between 21-48 µm, it can be said that drug loading could be 
increased by increasing microsphere size. Stabilizat ion 
method of microspheres (chemical vs. heat) could also be 
considered as another contributing factor in drug loading.  
In the preparation of salbutamol loaded albumin  
microspheres it was found that drug loading decreased by 
increasing both the time and temperature of denaturation 
condition
12
. In the present study it was noted that drug 
loading considerably increased when the percentage of the 
incorporated drug was increased from 2 (data not shown) to 
4. However drug loading was still low which might be 
attributed to the high temperatures used for microsphere 
stabilization and also to the high partition coefficient of the 
model drug which could lead to the loss of the drug due to its 
migrat ion to the organic phase. Mucoadhesion of BSA- 
propranolol microspheres was estimated to be on average 
75% which is in accordance with the previous report
14
. The 
high degree of mucoadhesion makes this system a good 
candidate for nasal delivery of the entrapped drug as it has 
previously been reported
16
. 
 
Figure 3: Plot of average percentage propranolol hydrochloride released from BSA microspheres in PBS pH 6.8 at 37
o
C as a 
function of time, each data point represents a value of mean±SD from three batches of microspheres  
Release studies were carried out on three batches of 
microspheres and showed a biphasic pattern in a way that 
about 40% of the drug released during the first 15 min  
followed by a more gradual release pattern reaching 70% 
after 12 hr. Figure 3 shows release profile of three batches as 
mean±SD values. The initial burst release could be related to 
the surface drug as well as small size microspheres (those in 
the size range of 1-5 µm) which might be due to the fact that 
smaller particles offered more surface area to release the 
drug. A similar release pattern has been reported elsewhere 
in which about 50% of the loaded drug released within 1 h 
which was attributed to the amount of drug adsorbed on the 
surface of microspheres
18
.    In another study a sustained 
release parenteral form of mitoxantrone loaded albumin  
microspheres was prepared for intraperitoneal administration 
to rats and found that the system released 75% of its drug 
contents in 10 h
10
. Another group reported 30% in itial release 
during the first 5 min from BSA-salbutamol microspheres 
followed by a very gradual release pattern which finally  
reached 100% after 24 h
12
. They also found that drug release 
from microspheres was remarkab ly slower than that of the 
plain drug. These authors suggested that various factors such 
as particle size, amount of loaded drug and denaturation 
conditions might affect release characteristics of 
microspheres, and it is possible to modulate the drug release 
rates by variation in the size as well as preparation conditions 
of the microspheres.  
In vitro diffusion studies across rat intestine (duodenum) 
were also carried out on three batches of microspheres and 
reported as average percentages of the diffused drug (Fig. 4). 
This experiment revealed that drug diffusion took place in a 
gradual pattern such that after 1 hour only about 10% of the 
drug diffused and drug diffusion reached 80% after 12 hours. 
The gradual diffusion may be attributed to the mucoadhesive 
properties of BSA microspheres which provide sustained and 
continuous release and diffusion of the drug from 
microspheric matrices. This makes the microsphere system 
of propranolol Hydrochloride as a sustained release (SR) 
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delivery system which has advantages of reducing the 
number of dosing, providing better patient compliance, 
reducing drug loss due to the first pass metabolism, and 
finally increasing drug bioavailability due to longer contact 
time of the delivery system with the absorption site. 
 
 
Figure 4:   Plot of percentage propranolol Hydrochloride loaded in BSA microspheres  diffused across rat duodenum at 37
◦
C as 
a function of time, each data point represents a value of mean±SD from three batches of BSA -propranolol hydrochloride 
microspheres  
CONCLUS ION  
Both release and diffusion patterns show that a sustained 
release form of the drug can be obtained by utilizing 
microsphere system of propranolol hydrochloride. Such a 
system has several advantages for drug delivery. In the case 
of propranolol hydrochloride which possesses low and 
variable b ioavailab ility with a high percentage of first pass 
metabolisms via the oral route, this system can provide a 
more steady plasma level of the drug. Having a h igh degree 
of mucoadhesion, this system can be used for the delivery of 
propranolol hydrochloride via nasal route which could 
eventually eliminate the first pass effect and thus improving 
drug's bioavailability.   
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